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The endothelial cells which form the inner cellular lining of the vasculature can act
as non-professional phagocytes to ingest and remove emboli and aged/injured red
blood cells (RBCs) from circulation. We previously demonstrated an erythrophagocytic
phenotype of the brain endothelium for oxidatively stressed RBCs with subsequent
migration of iron-rich RBCs and RBC degradation products across the brain
endothelium in vivo and in vitro, in the absence of brain endothelium disruption.
However, the mechanisms contributing to brain endothelial erythrophagocytosis are
not well defined, and herein we elucidate the cellular mechanisms underlying brain
endothelial erythrophagocytosis. Murine brain microvascular endothelial cells (bEnd.3
cells) were incubated with tert-butyl hydroperoxide (tBHP, oxidative stressor to induce
RBC aging in vitro)- or PBS (control)-treated mouse RBCs. tBHP increased the reactive
oxygen species (ROS) formation and phosphatidylserine exposure in RBCs, which
were associated with robust brain endothelial erythrophagocytosis. TNFα treatment
potentiated the brain endothelial erythrophagocytosis of tBHP-RBCs in vitro. Brain
endothelial erythrophagocytosis was significantly reduced by RBC phosphatidylserine
cloaking with annexin-V and with RBC-ROS and phosphatidylserine reduction with
vitamin C. Brain endothelial erythrophagocytosis did not alter the bEnd.3 viability,
and tBHP-RBCs were localized with early and late endosomes. Brain endothelial
erythrophagocytosis increased the bEnd.3 total iron pool, abluminal iron levels
without causing brain endothelial monolayer disruption, and ferroportin levels. In vivo,
intravenous tBHP-RBC injection in aged (17–18 months old) male C57BL/6 mice
significantly increased the Prussian blue-positive iron-rich lesion load compared with
PBS-RBC-injected mice. In conclusion, RBC phosphatidylserine exposure and ROS are
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key mediators of brain endothelial erythrophagocytosis, a process which is associated
with increased abluminal iron in vitro. tBHP-RBCs result in Prussian blue-positive ironrich lesions in vivo. Brain endothelial erythrophagocytosis may provide a new route
for RBC/RBC degradation product entry into the brain to produce iron-rich cerebral
microhemorrhage-like lesions.
Keywords: red blood cell, phosphatidylserine, oxidative stress, brain endothelial erythrophagocytosis, iron
deposits, cerebral microhemorrhages

RBCs is also a key trigger for erythrophagocytosis of oxidatively
stressed or aged RBCs by peripheral endothelial cells (Fens
et al., 2008, 2012). Similarly, our previous study reported a
marked externalization of RBC phosphatidylserine by tert-butyl
hydroperoxide (tBHP), an oxidative stressor used previously
to trigger erythrophagocytosis by peripheral endothelial cells
(Fens et al., 2012), and we found robust erythrophagocytosis
of tBHP-RBCs by murine brain microvascular endothelial cells
(Chang R. et al., 2018). Corroborating our findings, a recent
study reported increased erythrophagocytosis of aged RBCs by
the brain endothelium, which was associated with increased
phosphatidylserine externalization and oxidative stress (Catan
et al., 2019). These studies together show an association between
RBC phosphatidylserine exposure and oxidative stress, and
brain endothelial erythrophagocytosis, but a direct role of RBC
phosphatidylserine externalization and oxidative stress in this
process has not been reported.
The aim of the current study was to provide mechanistic
insights into the cellular pathways involved in brain endothelial
erythrophagocytosis. Murine RBCs were treated with tBHP to
induce oxidative stress and phosphatidylserine externalization
to study the role of these mediators in brain endothelial
erythrophagocytosis in vitro using murine brain microvascular
endothelial cells (bEnd.3). We further examined the impact
of brain endothelial erythrophagocytosis on the iron-transport
machinery of the bEnd.3 cells and the intracellular trafficking
of phosphatidylserine exposing tBHP-RBCs by tracing their
movement through early endosomes toward late endosomes,
the latter being the presumed site of RBC degradation and
release of iron-rich degradation products. Finally, we injected
tBHP-RBCs into aged mice to provide histological evidence for
increased iron-rich Prussian blue-positive lesion development
in mice. Overall, our findings provide important mechanistic
insights into the cellular pathways involved in, and the alterations
to cellular iron homeostasis associated with, brain endothelial
erythrophagocytosis.

INTRODUCTION
Cerebral microhemorrhages (CMHs) are small focal bleeds in the
brain that produce the magnetic resonance imaging signatures
of cerebral microbleeds (CMBs) (Greenberg et al., 2009). CMBs
increase with normal aging and under pathological conditions
and are primarily hemorrhagic in origin (e.g., cerebrovascular
disruption resulting in red blood cell (RBC) extravasation)
(Martinez-Ramirez et al., 2014; Fisher et al., 2018; Lau et al.,
2020). However, since CMBs are clinically identified as small
magnetic resonance imaging signal voids resulting from the
paramagnetic properties of iron in hemosiderin deposits, sources
of CMBs that arise due to an increase in hemosiderin iron via
alternate mechanisms have been suggested (Fisher, 2014; Janaway
et al., 2014).
Under physiological conditions, the adhesion of RBCs to
the vascular endothelium is negligible. However, an abnormal
RBC-vascular endothelial adhesion has been observed in various
pathological conditions (Bonomini et al., 2002; Nakagawa et al.,
2011; Wautier and Wautier, 2013; Kucukal et al., 2018).
Additionally erythrophagocytosis, a well-described feature of
macrophages, by which injured/aged erythrocytes are ingested,
digested, and cleared from the blood circulation, has been
described in peripheral endothelial cells (Fens et al., 2010, 2012;
Lee et al., 2011). A similar phagocytic phenotype has also
been reported for the brain endothelium, and studies show
that the brain endothelium can engulf and extrude emboli
to the abluminal (brain) side via angiophagy, in vivo and
in vitro (Grutzendler et al., 2014; van der Wijk et al., 2020).
Similarly, our recent in vitro and in vivo work demonstrated
an erythrophagocytic phenotype of the brain endothelium with
subsequent passage of iron-rich hemoglobin and RBCs across the
endothelial monolayer (Chang R. et al., 2018). The passage of
iron-rich RBCs (or RBC degradation products) across an intact
brain endothelium following erythrophagocytosis may present
an alternate source of iron-rich CMH-like lesions (Fisher, 2014;
Janaway et al., 2014; Chang R. et al., 2018).
Phosphatidylserine externalization on RBCs is wellrecognized as an important signal that initiates their phagocytic
removal from the circulation, and this mechanism is widely
studied for macrophage-mediated erythrophagocytosis (de
Back et al., 2014). Phosphatidylserine exposure on aged/injured

MATERIALS AND METHODS
Details about the source of the major resources used are in the
Supplementary Material.

Cell Culture

Abbreviations: CMBs, cerebral microbleeds; CMHs, cerebral microhemorrhages;
H2 DCFDA, 20 ,70 -dichlorodihydrofluorescein diacetate; EEA-1, early endosome
antigen 1; H&E, hematoxylin and eosin; ICP-MS, inductively coupled plasma
mass spectrometry; LAMP-1, lysosome-associated membrane protein 1; PBS,
phosphate-buffered saline; RBC, red blood cell; ROS, reactive oxygen species; tBHP,
tert-butyl hydroperoxide; TfR, transferrin receptor; ZO-1, zonula occludens - 1.
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Murine brain microvascular endothelial cells (bEnd.3
cells; American Type Culture Collection, Manassas, VA,
United States) were maintained in Dulbecco’s modified Eagle’s
medium (American Type Culture Collection, Manassas, VA,
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dilution, Santa Cruz Biotechnology, Dallas, TX, United States)
in PBS containing 1% bovine serum albumin (Thermo Fisher
Scientific, Waltham, MA, United States) for 45 min at room
temperature. After washing with PBS, the anti-CD47 antibody
was detected using the Alexa Fluor 647-labeled goat anti-rat
IgG (H + L) secondary antibody (1:2,000 dilution, Invitrogen,
Waltham, MA, United States) for 30 min in the dark, followed
by three PBS washes for flow cytometry detection.

United States) supplemented with 10% fetal bovine serum and
100 µg/ml penicillin/streptomycin (Sigma-Aldrich, St. Louis,
MO, United States) at standard cell culture conditions (5% CO2 ,
95% air). Cells between passages 22 and 31 were seeded onto
24- and 6-well plates (Corning, New York, NY, United States),
0.2% gelatin-coated glass coverslips, or Transwells with 0.4-µmpore polyester membrane inserts of a six-well plate (Corning,
New York, NY, United States) at a density of 1 × 105 cells/cm2 ,
unless otherwise stated.

Hematoxylin and Eosin (H&E) Staining

RBC Preparation and Treatment for
in vitro Experiments

H&E staining was performed as described previously (Chang R.
et al., 2018). bEnd.3 cells were fixed with 4% paraformaldehyde
and then stained with hematoxylin (Sigma-Aldrich, St. Louis,
MO, United States) and eosin Y (Sigma-Aldrich, St. Louis, MO,
United States) and mounted using Permount (Thermo Fisher
Scientific, Waltham, MA, United States). Ten continuous view
fields from three random areas per coverslip were imaged at × 40
magnification and manually quantified for total RBC number,
RBC-to-bEnd.3 ratio (expressed as %),% of bEnd.3 cells positive
for RBC, and % of bEnd.3 cells positive for RBC engulfment, as
described previously (Chang R. et al., 2018).

RBCs in Alsever’s solution were derived from 2- to 3-monthold male BALB/c mice (BioIVT, New York, NY, United States).
RBCs were resuspended in sterile phosphate-buffered saline
(PBS, without Ca2+ and Mg2+ ; Invitrogen, Waltham, MA,
United States) as control, or various concentrations (0.3, 1.0,
3.0 mM) of tBHP (Sigma-Aldrich, St. Louis, MO, United States)
at 37◦ C for 30 min. RBCs at a density of 2 × 106 /cm2 were
co-incubated with bEnd.3 cells with or without the 7.5-µg
annexin-V (BioLegend, San Diego, CA, United States) to cloak
phosphatidylserine, the antioxidant vitamin C (15–1,500 µM,
Sigma-Aldrich, St. Louis, MO, United States), to reduce ROS,
or inflammatory cytokine TNFα (10–100 ng/ml, BioLegend, San
Diego, CA, United States). The RBC-to-bEnd.3 ratio was ∼5:1 for
these experiments.

Hemoglobin Measurement
Hemoglobin was measured using 2,7-diaminofluorene (SigmaAldrich, St. Louis, MO, United States) as described previously
(Chang R. et al., 2018). bEnd.3 cells incubated with RBCs were
washed with PBS for total cellular hemoglobin (hemoglobin from
attached and engulfed RBCs) or quickly washed with distilled
water three times for intracellular hemoglobin (hemoglobin from
engulfed RBCs). Cells were lysed with urea lysis buffer (0.2 M
Tris–HCl buffer containing 6 M urea, Thermo Fisher Scientific,
Waltham, MA, United States) and mixed at a 1:1 ratio with
2,7-diaminofluorene reaction buffer (10 mg 2,7-diaminofluorene
in 10 ml urea lysis buffer containing 9% acetic acid and 0.3%
hydrogen peroxide). Absorbance was measured at 620 nm
using an absorbance plate reader (Molecular Devices, LLC, San
Jose, CA, United States). A set of hemoglobin standards (Lee
BioSolutions, Maryland Heights, MO, United States) was used to
calculate the amount of hemoglobin.

ROS Detection
Intracellular ROS were measured by the ROS-reactive fluorescent
indicator 20 ,70 -dichlorodihydrofluorescein diacetate (H2 DCFDA,
Molecular Probes, Carlsbad, CA, United States). Treated RBCs
(2 × 106 ) were incubated with 10 µM H2 DCFDA for 30 min at
37◦ C. The mean fluorescence intensity of DCF was measured at
485 nm/530 nm (excitation/emission) using a fluorescence plate
reader (Molecular Devices, LLC, San Jose, CA, United States).

Phosphatidylserine Exposure Detection
and Cloaking, and CD47 Detection
Annexin-V-FITC (BioLegend, San Diego, CA, United States)
was used to quantify phosphatidylserine externalization on the
RBC surface as per the manufacturer’s instructions. Briefly,
1 × 105 RBCs suspended in annexin-V blocking buffer (BD
Biosciences, Franklin Lakes, NJ, United States) were incubated
with 5 µg of annexin-V-FITC for 15 min in the dark, followed by
immediate analysis of the FITC signal using a BD Accuri C6 Plus
flow cytometer (BD Biosciences, San Jose, CA, United States).
Ten thousand events were recorded for each sample, and
RBCs were quantified using logarithmic gain for light scatter
and fluorescence channels with gating and background settings
defined through the PBS-RBCs. To determine the correct amount
of annexin-V required to block phosphatidylserine exposure,
phosphatidylserine-exposing RBCs were first incubated with
7.5 µg annexin V (BioLegend, San Diego, CA, United States)
and then labeled with annexin-V-FITC (5 µg), followed by FITC
detection using flow cytometry. For CD47 detection, 2.5 × 105
RBCs were incubated with the anti-CD47 antibody (1:200
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Cell Viability Assay
bEnd.3 cells (7,500 cells/well) seeded in 96-well plates (Corning,
New York, NY, United States) were assessed for cell viability
using the Cell Counting Kit-8 assay as per the manufacturer’s
instructions (Dojindo Molecular Technologies, Rockville, MD,
United States). Absorbance was measured at 450 nm using an
absorbance plate reader (Molecular Devices, LLC, San Jose, CA,
United States), and cell viability was adjusted to % of bEnd.3
control group (bEnd.3 cells with no RBC co-incubation).

Immunocytochemistry
After a 48-h incubation with RBCs, bEnd.3 cells were fixed
with 2% paraformaldehyde, permeabilized, and blocked with 5%
bovine serum albumin (Thermo Fisher Scientific, Waltham, MA,
United States) containing 0.1% Triton X-100 (Thermo Fisher
Scientific, Waltham, MA, United States). Cells were incubated
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drawn from calibration blanks with different concentrations
(4 nM–4 µM). Iron concentrations from independent samples
were calculated based on the calibrated iron standard curve.

with Alexa Fluor 647-labeled anti-early endosome antigen 1
(EEA-1) antibody (1:50 in PBS with 0.75% bovine serum albumin
and 0.1% Triton X-100; Santa Cruz Biotechnology, Dallas, TX,
United States) or rat anti-lysosome-associated membrane protein
1 (LAMP-1) antibody (the original antibody was diluted 1:2 in
50% glycerol followed by 1:5 dilution in PBS with 0.75% bovine
serum albumin and 0.1% Triton X-100; Developmental Studies
Hybridoma Bank, Iowa City, IA, United States) overnight at 4◦ C.
The anti-LAMP-1 antibody was detected using the Alexa Fluor
647-labeled goat anti-rat IgG (H + L) secondary antibody (1:200,
Santa Cruz Biotechnology, Dallas, TX, United States). Coverslips
were mounted with UltraCruz Aqueous Mounting Medium with
DAPI (Santa Cruz Biotechnology, Dallas, TX, United States)
and imaged at × 63 oil immersion objective with a Leica SP5
confocal microscope (Leica, Wetzlar, Germany). Z-stacks were
acquired with a z-step size of 0.5 µm. Each experimental group
had at least five coverslips, and 10 images per coverslip were
analyzed using ImageJ (NIH, Bethesda, MD, United States). Max
projection images were used to count nuclei and nuclei positive
for EEA-1/LAMP-1 staining as well as the number of RBCs.
The number of EEA-1/LAMP-1-positive RBCs was determined
by examining each image in a z-stack to find RBCs localized
with EEA-1/LAMP-1 in the same plane. We quantified (1) RBC
attachment (expressed as % of number of bEnd.3 cells), (2) RBCs
localized to the nucleus (expressed as % of total RBC), (3) EEA-1/LAMP-1-positive RBCs (expressed as % of total RBCs found in
the imaging field of view), and (4) RBCs in the nucleus positive
for EEA-1-/LAMP-1 (expressed as a % of RBCs in the nucleus).

Western Blot
bEnd.3 cells were washed with PBS and lysed with
radioimmunoprecipitation assay buffer containing cocktail
protease inhibitors (Bio-Rad, Hercules, CA, United States)
and boiled with Laemmli buffer and 10% 2-mercaptoethanol
(Bio-Rad, Hercules, CA, United States). Blots were probed
with anti-transferrin receptor (TfR) antibody (1:1,000 dilution;
Thermo Fisher Scientific, Waltham, MA, United States) or
anti-ferroportin antibody (1:1,000 dilution; Novus Biologicals,
Littleton, CO, United States) overnight at 4◦ C. Membranes were
exposed to the appropriate horseradish peroxidase–conjugated
secondary antibodies, followed by chemiluminescence detection
(Thermo Fisher Scientific, Waltham, MA, United States). Equal
protein loading was controlled by re-probing the membrane
with anti–β-actin antibody (1:1,000 dilution; Santa Cruz
Biotechnology, Dallas, TX, United States). Chemiluminescence
was detected using the UVP ChemiDoc-It TS2 Imager
(Upland, CA, United States), and Image J (NIH, Bethesda, MD,
United States) was used for Western blot signal quantification.

In vivo Prussian Blue-Positive Iron-Rich
Lesion Development
All animal procedures were approved by University of CaliforniaIrvine’s Institutional Animal Care and Use Committee and
carried out in compliance with University Laboratory Animal
Resources regulations. Blood was collected from 17–18-monthold male C57BL/6 mice (National Institute of Aging, Bethesda,
MD, United States) and mixed with 3.2% sodium citrate
(0.1/0.9 ml of blood). Blood was centrifuged at 500g for 10 min
at 4◦ C, and RBC pellet was washed with PBS three times. Purified
RBCs were resuspended in sterile PBS (without Ca2+ and Mg2+ ;
Invitrogen, Waltham, MA, United States) as control, or 3 mM
of tBHP (Sigma-Aldrich, St. Louis, MO, United States) at 37◦ C
for 30 min. After centrifuging at 500g for 5 min at 4◦ C, the
RBC pellet was resuspended in sterile PBS. PBS- or tBHP-RBCs
(3 × 108 cells per mouse) were then injected intravenously via
the retro-orbital route under brief isoflurane anesthesia into
different 17–18-month-old male C57BL/6 mice (n = 3 per group).
Seven days after RBC injection, cardiac perfusion was performed,
and brains were harvested and fixed with 4% paraformaldehyde.
Hemi-brains were cut into 40-µm coronal sections, and every
sixth section was used to examine Prussian blue-positive lesions
as described previously (Sumbria et al., 2016). Prussian bluepositive lesions were counted at × 20 magnification by a blinded
observer, and digital images were used to calculate lesion size
(µm2 ) and positive area (expressed as a percent of total tissue
area analyzed) using the NIH ImageJ software 1.62, as described
previously (Sumbria et al., 2016).

Iron Level Measurement
Iron levels in cell samples (total and intracellular iron) and
migration of intracellular iron across the bEnd.3 monolayer
were measured by Agilent 8900 Triple Quadrupole Inductively
Coupled Plasma Mass Spectrometry (ICP-MS; Agilent, Santa
Clara, CA, United States). For total cellular and intracellular iron,
bEnd.3 cells (9.5 × 105 per well) were seeded in 6-well plates and
incubated with 1 × 108 RBCs per well for 48 h. The RBC-tobEnd.3 ratio was ∼ 25:1 for these experiments. Cells were washed
three times with PBS for total cellular iron (iron from attached
and engulfed RBCs) or distilled water for intracellular iron (iron
from engulfed RBCs). Samples were lysed with 1 ml 4% nitric acid
at 80◦ C for 3 h, after which 250 µl 30% hydrogen peroxide was
added and the samples were further digested for 1 h at 90◦ C.
To measure passage of intracellular iron across the endothelial
monolayer, bEnd.3 cells were grown on six-well Transwell inserts
(pore size 0.4 µm, Corning New York, NY, United States).
The integrity of the bEnd.3 monolayer in Transwell inserts was
assessed by measuring the transendothelial electrical resistance
using the EVOM2 Epithelial Volt/Ohm Meter and an STX-2
electrode system (World Precision Instruments LLC, Sarasota,
FL, United States). After the transendothelial electrical resistance
measurements stabilized, 1 × 108 RBCs were added into each
insert seeded with the bEnd.3 cells, for 48 h. Apical and
basolateral media were collected separately, and 67% nitric acid
was added to each sample to result in a final nitric concentration
of 4%. Samples were digested for 3 h at 80◦ C, and 250 µl 30%
hydrogen peroxide per 1-ml media sample was added. Samples
were further digested at 90◦ C for 1 h. Standard curves were

Frontiers in Cell and Developmental Biology | www.frontiersin.org

Zonula Occludens-1 (ZO-1)
Immunostaining
For each mouse (n = 3 per group), three coronal sections
(600 µm apart and 40 µm thick) prepared as above were used
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for ZO-1 immunostaining. Briefly, brain sections were incubated
in quenching solution (0.2% Triton X-100 (Thermo Fisher
Scientific, Waltham, MA, United States) including 20 mM glycine
(Sigma-Aldrich, St. Louis, MO, United States) in PBS) for 1 h,
followed by blocking with 0.5% bovine serum albumin (Thermo
Fisher Scientific, Waltham, MA, United States) containing
0.3% Triton X-100 (Thermo Fisher Scientific, Waltham, MA,
United States) for 1 h. Brain sections were incubated with a rabbit
ZO-1 polyclonal antibody (1:100 dilution in blocking buffer,
Invitrogen, Waltham, MA, United States) overnight at 4◦ C. The
anti-ZO-1 antibody was detected using Alexa Fluor 647-labeled
goat anti-rabbit IgG (H + L) secondary antibody (1:400 dilution
in blocking buffer, Invitrogen, Waltham, MA, United States).
Brain sections were imaged using a × 60 oil immersion objective
with the Nikon Ti-Eclipse microscope (Nikon, Melville, NY,
United States), and three cortical images were taken per mouse.
Z-stacks were acquired, and max projection images were used
to quantify the ZO-1-positive area (expressed as a percent
of total tissue area analyzed) using ImageJ (NIH, Bethesda,
MD, United States).

Statistical Analysis
The data are shown as means ± SEM. Student’s t-test or the
Mann–Whitney U test was used to compare two independent
groups, and one-way analysis of variance (ANOVA) with Holm–
Sidak post hoc test to compare more than two independent
groups. To test the effect of two factors, two-way ANOVA
with Holm–Sidak post hoc test was used. GraphPad Prism 8.0
(GraphPad Software, Inc., La Jolla, CA, United States) was
used for statistical analyses, and a p ≤ 0.05 was considered
statistically significant.

FIGURE 1 | ROS production and phosphatidylserine exposure in PBS- or
tBHP-RBCs. ROS level (A) and phosphatidylserine exposure (B,C) were
measured by H2 DCFDA and annexin-V-FITC, respectively, after a 30-min
incubation with PBS or tBHP. Data are presented as mean ± SEM of three
independent experiments done in duplicate. One-way (A) or two-way (B)
ANOVA with Holm–Sidak post hoc test was used. ***p < 0.001. $ p < 0.05
compared with the corresponding PBS-RBC group.

RESULTS

As shown in Figure 1A, tBHP (0.3–3 mM) induced a 300–
400% increase in ROS levels in RBCs compared with PBSRBCs. tBHP treatment resulted in a >900% increase in
annexin-V-FITC-positive RBCs compared with PBS treatment,
indicating significant phosphatidylserine exposure in tBHPRBCs (Figures 1B,C).

number of endothelial cells positive for tBHP-RBCs (Figure 2D).
Although not statistically significant, there was a trend toward an
increase in the engulfment of tBHP-RBCs by the bEnd.3 cells at
48 h (Figure 2E). No significant erythrophagocytosis with PBS
control was observed at 24 or 48 h (Figures 2A–C). Based on
these results, a 48-h co-incubation of RBCs and bEnd.3 was used
for subsequent studies. Interestingly, we saw a dose-dependent
increase in brain endothelial erythrophagocytosis of tBHP-RBCs
with TNFα (10–100 ng/mL) (Supplementary Figure 1).

Temporal Increase in
Erythrophagocytosis by bEnd.3 Cells

Role of Phosphatidylserine Exposure in
Brain Endothelial Erythrophagocytosis

Our previous study reported a temporal increase in the
erythrophagocytosis of tBHP-RBCs (3 mM dose) by the bEnd.3
cells up to 24 h (Chang R. et al., 2018). To further investigate
the timeline of erythrophagocytosis of tBHP-RBCs, studies were
done following a 24- or 48-h co-incubation of bEnd.3 cells with
RBCs. The increased attachment of tBHP-RBCs to the bEnd.3
cells is evident in Figure 2A, where the RBCs appear as small
red/brown dots on H&E-stained bEnd.3 cells. Compared with the
24-h timepoint, exposure up to 48 h further increased the number
of RBCs attached to the bEnd.3 cells (Figures 2A–C) and the

We used annexin-V to mask the externalized phosphatidylserine
on the surface of tBHP-RBCs. As shown in Figure 3A,
preincubation of tBHP-RBCs with 7.5 µg of annexin-V followed
by incubation with annexin-V-FITC reduced the annexinV-FITC signal equivalent to PBS-control values, indicating
complete cloaking of tBHP-induced phosphatidylserine exposure
(Figure 3A). Phosphatidylserine masking by annexin-V led to a
significant decrease in brain endothelial erythrophagocytosis. As
shown in Figure 3, there was a 78% decrease in the adhesion of
tBHP-RBCs, a 69% decrease in the number of RBCs attached per

ROS Production and Phosphatidylserine
Exposure

Frontiers in Cell and Developmental Biology | www.frontiersin.org
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FIGURE 2 | Temporal increase in brain endothelial erythrophagocytosis. Significant time-dependent increase in adhesion (A–D) and a trend toward increased
engulfment (E) of tBHP-RBCs compared with PBS-RBCs using H&E staining and light microscopy. RBCs are seen as small red/brown dots, and bEnd.3 nuclei are
stained purple with hematoxylin in A. Data are presented as mean ± SEM of three independent experiments done in duplicates. Two-way ANOVA with Holm–Sidak
post hoc test was used. *p < 0.05, **p < 0.01. Scale bar = 50 µm.

the effect of free radical scavenging on brain endothelial
erythrophagocytosis. As shown in Figure 4C, vitamin C (15 and
1,500 µM) treatment reduced the total cellular hemoglobin level
in bEnd.3 cells by 30–47%. Vitamin C (1,500 µM) treatment
resulted in a 31% reduction of intracellular hemoglobin level,
which shows that vitamin C reduced the engulfment of tBHPRBCs by the bEnd.3 cells. These results were confirmed by H&E
staining (Figure 4D).

bEnd.3 cell, and a 28% decrease in bEnd.3 cells positive for RBCs
(Figures 3B–E). Further, the bEnd.3 cells positive for engulfed
RBCs were reduced by 48% (Figure 3F). No significant change
in RBC adhesion and/or engulfment was observed in the control
PBS-RBC group in the presence of annexin-V (Figures 3B–F).
To determine the impact of phosphatidylserine masking
on cellular levels of the iron-rich RBC degradation product,
hemoglobin, we measured the total and intracellular hemoglobin
levels in bEnd.3 cells following a 48-h incubation with
RBCs and annexin-V. In the absence of phosphatidylserine
cloaking, the total and intracellular hemoglobin levels of bEnd.3
cells incubated with tBHP-RBCs were 6.5 ± 0.4 µg/ml and
2.3 ± 0.1 µg/ml, respectively (Figure 3G). These hemoglobin
levels were significantly higher than those in the bEnd.3-only
group (without RBCs) and PBS-RBC group (Figure 3G), further
supporting the H&E results (Figures 3B–F). In the presence of
annexin-V, the total and intracellular hemoglobin levels in bEnd.3
cells incubated with tBHP-RBCs decreased by 77% and 75%,
respectively (Figure 3G). No significant difference in bEnd.3 cell
viability was observed after incubation with PBS- or tBHP-RBCs
for 48 h, and in the presence of annexin-V (Figure 3H).

Intracellular Trafficking of RBCs in Brain
Endothelial Cells
We investigated the trafficking of RBCs within the bEnd.3
cells by immunofluorescence to visualize the engulfed RBCs
in early and late endosomes. Figures 5A,B show tBHP-RBCs
(white/yellow) surrounded by an early endosomal marker, EEA1 (red), and a late endosomal marker, LAMP-1 (red), within
the bEnd.3 cells. 3D reconstructions of the z-stack images
confirmed the internalization of tBHP-RBCs in the bEnd.3 cells
(Supplementary Figure 2). Our quantification results show that
∼26% of tBHP-RBCs were co-localized with EEA-1- and LAMP1-positive vesicles (Figures 5C,D). Interestingly, ∼12–15% of
tBHP-RBCs were found to co-localize with the nuclear stain
DAPI (Figures 5C,D and Supplementary Figure 2).

Suppression of Brain Endothelial
Erythrophagocytosis by Vitamin C
Since tBHP is a robust oxidative inducer and causes
phosphatidylserine exposure in RBCs, we investigated
if suppression of ROS by antioxidant vitamin C alters
phosphatidylserine externalization. A 1-h incubation with
vitamin C (1.5–1,500 µM) led to a significant reduction of
ROS level in tBHP-RBCs (Figure 4A) but had no effect on
PBS-RBCs. Notably, vitamin C at a concentration of 1,500 µM
led to a full abolishment of ROS accumulation in tBHP-RBCs
(Figure 4A). Vitamin C (15 and 1,500 µM) also reduced
phosphatidylserine exposure of tBHP-RBCs by 38% and 88%,
respectively (Figure 4B). The above prompted us to investigate
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Increase in Cellular and Abluminal Iron
Following Brain Endothelial
Erythrophagocytosis
For brain endothelial erythrophagocytosis to produce iron-rich
lesions in the brain, the former must be accompanied with
an increase in intracellular iron and subsequent basolateral
(abluminal) iron. We therefore measured the accumulation of
iron in the bEnd.3 cells and the basolateral iron across the
endothelial monolayer by ICP-MS. After a 48-h incubation
with tBHP-RBCs, total cellular iron levels (iron from attached
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FIGURE 3 | Phosphatidylserine exposure plays an important role in brain endothelial erythrophagocytosis. Phosphatidylserine exposure of tBHP-RBCs was blocked
by annexin-V (A). Both RBC adhesion and engulfment were significantly suppressed by annexin-V (B–F). The total cellular and intracellular hemoglobin levels were
significantly reduced by annexin-V following a 48-h incubation (G). Erythrophagocytosis did not alter brain endothelial cell viability following the 48-h incubation (H).
RBCs are seen as small red/brown dots, and bEnd.3 nuclei are stained purple with hematoxylin in panel (B). Data are presented as mean ± SEM of three
independent experiments done in duplicate. One-way (H) or two-way (A,C–G) ANOVA with Holm–Sidak post hoc test was used. ***p < 0.001, ****p < 0.0001
compared with the corresponding bEnd.3-only group and PBS-RBC group; ## p < 0.01, ### p < 0.001 compared with tBHP-RBCs without annexin-V; $ p < 0.0001.
Scale bar = 50 µm. NS is “not significant”.

group (Figure 6D). A significant 27% increase in ferroportin
protein levels was observed in the bEnd.3 cells incubated with
tBHP-RBCs compared with the bEnd.3-only and PBS-RBC
groups (Figure 6E).

and engulfed RBCs) of bEnd.3 cells increased by 311%
compared with bEnd.3-only and 298% compared with PBSRBC groups (Figure 6A). To further investigate the impact
of RBC engulfment on intracellular iron levels, bEnd.3 cells
were washed with distilled water to lyse the attached RBCs
on the endothelial surface. Intracellular iron levels increased
49% after the incubation of the bEnd.3 cells with tBHPRBCs compared with PBS-RBCs (Figure 6B). An in vitro
Transwell system was used to measure iron transmigration
across the bEnd.3 monolayer. At 48 h after RBC incubation,
basolateral iron levels in the tBHP-RBC group were 205%
and 76% higher than those in the bEnd.3-only group and
PBS-RBC group, respectively (Figure 6C). To rule out the
contribution of free iron in the apical medium to the
increased basolateral iron levels in Figure 6C, we measured
free iron levels in the media from PBS- or tBHP-RBCs
(in the absence of bEnd.3 cells). No significant differences
were observed in the levels of free iron over the course of
48 h between the PBS and tBHP groups (Supplementary
Figure 3A). No changes in transendothelial electrical resistance
(Supplementary Figures 3B,C) were observed following PBSand tBHP-RBC incubation. Further, we investigated the protein
levels of the major iron influx transporter, the TfR, and
the iron exporter, ferroportin. After a 48-h incubation with
tBHP-RBCs, no significant change in TfR protein levels was
observed compared with the bEnd.3-only group and PBS-RBC

In vivo Prussian Blue-Positive CMH-Like
Lesion Development
To determine if tBHP-RBCs produce iron-rich CMH-like lesions,
aged mice were injected with PBS- or tBHP-RBCs. The mice
injected with PBS- or tBHP-RBCs recovered quickly after
intravenous RBC injection, appeared normal, and survived the
duration of the study (7 days). All aged mice injected with either
PBS-RBCs or tBHP-RBCs developed Prussian blue-positive ironrich lesions. The total Prussian blue-positive area (expressed as
a % of brain tissue area analyzed) and size of the individual
lesion were, however, greater (p = 0.05) in mice injected with
tBHP-RBCs than in mice injected with PBS-RBCs (Figures 7A–
C). No significant difference was observed in the blood–brain
barrier tight-junction protein ZO-1-positive area between the
mice injected with PBS-RBCs or tBHP-RBCs (Figure 7D).

R
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DISCUSSION
Our previous work showed that oxidatively stressed RBCs can
undergo robust erythrophagocytosis by the brain endothelium,
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FIGURE 4 | Vitamin C (Vit C) reduced brain endothelial erythrophagocytosis. ROS level (A) and phosphatidylserine exposure (B) were suppressed by Vit C
(15–1,500 µM) after incubation with tBHP-RBCs. The total cellular and intracellular hemoglobin levels of bEnd.3 cells treated with tBHP-RBCs were significantly
reduced following a 48-h incubation with Vit C (C). Representative H&E-stained images of bEnd.3 cells following the 48-h incubation with Vit C-treated RBCs (D).
RBCs are seen as small red/brown dots, and bEnd.3 nuclei are stained purple with hematoxylin in panel (D). Data are presented as mean ± SEM of three
independent experiments done in duplicate. Two-way ANOVA with Holm–Sidak post hoc test was used. ***p < 0.001 as indicated. ## p < 0.01, #### p < 0.0001
compared with the corresponding tBHP-RBC + Vit C 0 µM group. $ p < 0.05, $$$ p < 0.001, $$$$ p < 0.0001 tBHP-RBC group compared with the corresponding
PBS-RBC and bEnd.3-only groups.

close contact with circulating RBCs, are also reported to have an
erythrophagocytic phenotype. Fens et al. (2010) reported that
peripheral endothelial cells can phagocytose RBCs subjected
to increased oxidative stress and phosphatidylserine exposure.
Similarly, a recent study showed that RBC aging and glycation
increases phosphatidylserine externalization and oxidative stress
in RBCs, which is associated with enhanced RBC phagocytosis
by the vascular endothelium (Catan et al., 2019). Overall, the
contribution of the endothelium to erythrophagocytosis and
clearance of injured RBCs is now increasingly reported, as is the
involvement of phosphatidylserine exposure and oxidative stress
in endothelial erythrophagocytosis. Our recent work extended
these findings to the brain endothelium and showed robust
brain endothelial erythrophagocytosis of phosphatidylserine
exposing tBHP-RBCs (Chang R. et al., 2018). To establish
the definitive contribution of RBC phosphatidylserine
exposure to brain endothelial erythrophagocytosis, herein
we cloaked phosphatidylserine with annexin-V which has
a high binding affinity for phosphatidylserine in a calciumdependent manner (Figure 3A; Lizarbe et al., 2013). Cloaking
of RBC phosphatidylserine with annexin-V significantly
reduced erythrophagocytosis of tBHP-RBCs by the bEnd.3 cells
(Figures 3B–F). Annexin-V also significantly reduced total
and intracellular hemoglobin, an iron-rich RBC degradation
product, in the bEnd.3 cells (Figure 3G), confirming the
role of RBC surface phosphatidylserine exposure in brain
endothelial erythrophagocytosis. Mechanistically, studies

and this process was accompanied by an increase in the migration
of an iron-rich RBC degradation product (hemoglobin) and
RBCs across the brain endothelium, in vitro and in vivo, in
the absence of vascular disruption (Chang R. et al., 2018). In
the present report, we elucidate the cellular mechanisms that
contribute to brain endothelial erythrophagocytosis. We show
that phosphatidylserine cloaking and oxidative stress reduction
significantly attenuate brain endothelial erythrophagocytosis in
the in vitro murine brain microvascular endothelial cell model.
Further, brain endothelial erythrophagocytosis alters endothelial
iron homoeostasis and increases abluminal (brain) iron, without
loss of the brain endothelial monolayer integrity, in vitro. Finally,
we provide histological evidence for increased iron-rich Prussian
blue-positive lesion load in mice injected with tBHP-RBCs,
correlating with the in vitro increase in abluminal iron.
RBCs have a life span of 120 days in humans and about
45 days in mice (Gottlieb et al., 2012). ROS accumulation
has been suggested to be a key RBC-life-span determinant by
causing phosphatidylserine scrambling and externalization.
Phosphatidylserine exposure contributes to the recognition
of old/damaged RBCs by altering RBC adhesion to
professional phagocytes (macrophages), which is followed
by erythrophagocytosis and RBC clearance from the circulation
(Franco, 2012; Gottlieb et al., 2012). Besides professional
phagocytes, other cell types such as smooth muscle cells can
phagocytose phosphatidylserine-exposing apoptotic bodies and
aged RBCs (Garfield et al., 1975). Endothelial cells, which are in
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FIGURE 5 | A subset of tBHP-RBCs localized to early and late endosomes. bEnd.3 cells were stained for early endosome antigen 1 (EEA-1; red) (A),
lysosome–associated membrane protein 1 (LAMP-1; red) (B), and 40 ,6-diamidino-2-phenylindole (DAPI; blue) after a 48-h incubation with PBS- or tBHP-RBCs.
RBCs are indicated by yellow arrowheads in panels (A,B). Massive accumulation of tBHP-RBCs within bEnd.3 cells is shown in panel (B). Orthogonal projections
from z-stacks of confocal images show tBHP-RBCs co-localized with the endosomal markers in bEnd.3 cells (white arrowheads in A,B). Scale bar = 20 µm.
Quantification of RBC attachment (expressed as % of number of bEnd.3 cells), RBCs localized to the nucleus (expressed as % of total RBCs; also see
Supplementary Figure 2), EEA-1- and LAMP-1-positive RBCs (expressed as % of total RBCs), and RBCs in the nucleus positive for EEA-1-/LAMP-1 (expressed
as a % of RBCs in the nucleus) (EEA-1: C and LAMP-1: D). All experiments were repeated at least three times.

Notably, endothelial cell viability was not altered with brain
endothelial erythrophagocytosis up to 48 h, which is consistent
with the observations in human peripheral vascular endothelial
cells (Catan et al., 2019). It should be noted that despite the
almost complete reversal of phosphatidylserine exposure with
phosphatidylserine masking with annexin-V (Figure 3) and the
highest concentration of vitamin C (Figure 4), brain endothelial
erythrophagocytosis was not completely abolished by these
agents. These results suggest the involvement of alternate
molecular mechanisms of brain endothelial erythrophagocytosis.
In this regard, studies show the involvement of vascular cell
adhesion molecule 1 (VCAM-1) and intercellular adhesion
molecule 4 (ICAM-4) in erythrocyte adhesion to endothelial
cells under pathological conditions (Wautier and Wautier,
2013). The expression of these adhesion molecules is increased
by pro-inflammatory cytokines, including TNFα. Although we
did not study the role of these adhesion molecules on brain
endothelial erythrophagocytosis, treatment of brain endothelial
cells and tBHP-RBCs with TNFα significantly enhanced brain
endothelial erythrophagocytosis in a dose-dependent manner
(Supplementary Figure 1), showing the role of inflammation
in potentiating brain endothelial erythrophagocytosis, in vitro.
Besides phosphatidylserine and adhesion molecules, CD47 on
the RBC surface is a well-studied “eat me” or “don’t eat me”

show that phosphatidylserine-dependent erythrophagocytosis
by endothelial cells is mediated by the αv integrins or
phosphatidylserine-recognizing transmembrane receptors,
stabilin-1 and stabilin-2 (Lee et al., 2011; Fens et al., 2012). Besides
these, phosphatidylserine-recognizing receptors, including
tyrosine kinase receptors, CD300, T-cell immunoglobulin, and
mucin domain 1 and 4, are involved in the erythrophagocytosis
of phosphatidylserine-exposing RBCs by macrophages,
but the involvement of these receptors in endothelial
erythrophagocytosis has not been reported and needs further
investigation (Klei et al., 2017; Chang C. F. et al., 2018).
Besides RBC phosphatidylserine exposure, tBHP-RBCs
showed a dose-dependent increase in intracellular ROS
levels in the current study (Figure 1). Given that tBHP is
a potent oxidative stressor (Fens et al., 2012; Chang R.
et al., 2018), we investigated the involvement of oxidative
stress in brain endothelial erythrophagocytosis. For this, we
incubated tBHP-RBCs with vitamin C, a ROS scavenger.
Vitamin C treatment resulted in a 90% reduction of ROS
accumulation and phosphatidylserine exposure of tBHP-RBCs
(Figures 4A,B). Accordingly, we observed a significant reduction
in erythrophagocytosis of tBHP-RBCs, indicating that both
ROS production and phosphatidylserine exposure play a vital
role in the brain endothelial erythrophagocytosis (Figure 4).
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FIGURE 6 | Brain endothelial erythrophagocytosis increased cellular iron load and abluminal iron. Significant increase in total cellular iron (iron from attached and
engulfed RBCs) (A) and intracellular iron (iron from engulfed RBC) (B) in bEnd.3 cells following a 48-h incubation with tBHP-RBCs. Significant increase in basolateral
iron levels after the 48-h incubation with tBHP-RBCs (C). No change in the levels of iron importer, transferrin receptor (TfR) (D), but an increase in the levels of iron
exporter, ferroportin (E), in bEnd.3 cells after the 48-h incubation with PBS- or tBHP-RBCs. Data are presented as mean ± SEM of three independent experiments
done in duplicates. One-way ANOVA with Holm–Sidak post hoc test was used. *p < 0.05, **p < 0.01, ***p < 0.001. NS is “not significant”.

were added to the bEnd.3 monolayer, incubated for 48 h, after
which the bEnd.3 media were replaced with fresh media, and the
attached RBCs were incubated with the bEnd.3 cells for another
72 h (all the free-floating RBCs were removed with the medium
change). The tBHP-RBCs attached to the bEnd.3 cells after 72 h
(RBCs appear as black spots in Supplementary Figure 2D) were
reduced. The total cellular iron levels in the tBHP-RBC-treated
bEnd.3 cells were not significantly different from the PBS-RBCtreated bEnd.3 cells, suggesting that the tBHP-RBCs were not
present inside the bEnd.3 cells (data not shown). When we
measured the iron in the media to determine if the RBCs had
internalized and degraded and the resulting iron released to the
media, we found a small but significantly higher iron level in the
media collected from the bEnd.3 cells incubated with tBHP-RBCs
compared with PBS-RBCs (Supplementary Figure 2E). These
results suggest that with time, the engulfed RBCs are degraded
within the lysosome, as implicated by RBCs co-localized with
LAMP-1 (Figure 5), and the resulting iron released into the
media. Contrary to this, a recent study showed that microspheres
and emboli are retained in the brain endothelial cells without
degradation, triggering their transmigration (van der Wijk et al.,
2020). Our previous in vivo work showed a similar phenomenon
of RBC migration across the brain endothelium (Chang R.
et al., 2018), and some of the engulfed RBCs may eventually
transmigrate across the brain endothelium. Overall, although

signal and regulates erythrophagocytosis through its interaction
with signal-regulatory protein alpha that is expressed on
phagocytes including endothelial cells (Burger et al., 2012).
We found a significant 27% reduction in CD47 expression
in tBHP-RBCs compared with PBS-RBCs (Supplementary
Figure 4). Future work will be needed to determine the role
of the CD47-signal-regulatory protein alpha pathway in brain
endothelial erythrophagocytosis.
The intracellular processing of RBCs by macrophages
following erythrophagocytosis has been extensively studied
and involves engulfment of the damaged/injured RBCs into
phagosomes via phagocytosis, fusion of the phagosome with the
lysosome, lysosomal degradation of the RBC, and release of RBC
degradation products into the cytosol (Korolnek and Hamza,
2015). Before fusing with the lysosomes, the phagosomes undergo
a regulated sequence of fusion events, which involves fusion with
the organelles in the endocytic pathway (Duclos et al., 2000). The
endocytic pathway is composed of several distinct compartments
based on their functions. For example, early endosomes play
a primary role in sorting and recycling, while late endosomal
compartments, such as lysosomes, serve as a final destination for
proteolytic degradation (Hu et al., 2015). Our results demonstrate
that a subset of internalized tBHP-RBCs is co-localized with
both early and late endosome markers (Figure 5). To examine
the fate of the remaining attached RBCs, tBHP- or PBS-RBCs
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In the current study, brain endothelial erythrophagocytosis
was accompanied with a significant increase in the intracellular
iron pool (Figure 6), which is consistent with previous
work showing an increase in cellular iron load with
erythrophagocytosis by professional phagocytes (Knutson
et al., 2003). Additionally, and more relevant from the standpoint
of iron-rich CMH-like lesion development, we showed an
increase in migration of iron across an intact endothelial
cell monolayer, providing direct evidence for increased
abluminal iron with brain endothelial erythrophagocytosis.
These results build on our prior report that brain endothelial
erythrophagocytosis was accompanied by passage of hemoglobin
across the brain endothelial monolayer with unaltered brain
endothelial monolayer integrity (Chang R. et al., 2018). Sources
of abluminal iron in the current study could be hemoglobin
or cytosolic iron (iron released after lysosomal degradation
within the brain endothelial cells) which migrates across the
brain endothelial monolayer. These results show that brain
endothelial erythrophagocytosis is associated with an increase
in abluminal (brain facing) iron load. Once in the brain
parenchyma, microglial cells are well equipped to clear RBC and
its degradation products, including hemoglobin, via scavenger
receptors including CD36, CD47, CD163, and CD91 (Pan et al.,
2020). Within the microglial cells, hemoglobin can be broken
down into free heme followed by free iron that is stored as the
insoluble hemosiderin-iron. Similarly, brain iron homeostasis
is tightly regulated by the blood–brain barrier transferrin
receptors, apotransferrin released by the oligodendrocytes, and
iron transporters present on the ependymal surface. Transferrinbound iron can also be taken up by astrocytes or neurons
that express transferrin receptors. Any excess iron released
from hemoglobin degradation may be stored as ferritin-iron
(Wagner et al., 2003).
Increased cellular iron load after erythrophagocytosis is
associated with alterations in iron transport proteins (Knutson
et al., 2003). To elucidate the impact of brain endothelial
erythrophagocytosis on the brain endothelial iron transporters,
we measured levels of TfR, the major iron influx transporter,
and ferroportin, the only known iron exporter at the blood–
brain barrier (Ganz, 2005; Moos et al., 2007; McCarthy and
Kosman, 2015). TfRs are localized to the luminal and abluminal
surface of the brain microvasculature (Huwyler and Pardridge,
1998) and facilitate iron uptake into the brain microvascular
endothelial cells and export into the brain via receptormediated transcytosis (Moos et al., 2007). Similarly, studies
show that ferroportin is also localized to both the luminal and
abluminal surfaces of the brain microvasculature to facilitate
iron export from the brain endothelial cells (Wu et al., 2004;
McCarthy and Kosman, 2015). In the current study, brain
endothelial erythrophagocytosis was not associated with a change
in TfR protein levels; however, ferroportin protein levels were
significantly increased (Figure 6). This is consistent with an
increase in ferroportin levels following erythrophagocytosis by
macrophages (Knutson et al., 2003) and may be a compensatory
response to maintain iron homeostasis and prevent iron
overloading within the endothelial cells (Chiou et al., 2019).
This also provides a potential explanation for why the brain

FIGURE 7 | In vivo iron-rich Prussian blue-positive cerebral microhemorrhage
(CMH)-like lesion development. Aged mice injected with tBHP-RBCs had a
higher total Prussian blue-positive lesion area (A) and individual lesion size (B)
compared with the mice injected with PBS-RBCs. Representative
Prussian-blue-positive lesions in mice injected with PBS- or tBHP-RBCs (C).
No significant difference in the ZO-1-positive area between the mice injected
with tBHP-RBCs and PBS-RBCs was observed (D). Data are presented as
mean ± SEM of n = 3 per group. Scale bar = 200 µm in panel (C) and 25 µm
in panel (D). ∗ p = 0.05 with a Mann–Whitney U test.

the massive engulfment of tBHP-RBCs by some endothelial cells
may overwhelm the abovementioned clearance mechanisms at
some point, increase the intracellular iron pool, and trigger
endothelial cell apoptosis, we did not observe overt endothelial
cell death up to 5 days (48 + 72 h) following RBC incubation
(Supplementary Figure 2D). However, we, cannot rule out
apoptosis, although only a fraction of HUVEC cells showed
signs of apoptosis post-erythrophagocytosis following 24 h of
incubation (Fens et al., 2012).
We observed RBCs not only in the cytosol but also in the
nucleus (Figure 5 and Supplementary Figure 2). Trafficking
of cargo to the nucleus has been reported previously and been
shown to impact cellular function and regulate gene expression
(Olsnes et al., 2003; Chaumet et al., 2015). Further, cellular
trafficking is dependent on the size of cargo, such that large cargos
(3 µm) are directed to the nucleus for digestion (Keller et al.,
2017). It is therefore conceivable that the large size of the RBC
sorts them to the nucleus in the current study. This finding of
RBC trafficking to the endothelial cell nucleus is novel, and its
implication needs to be further investigated.
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glycated RBCs is associated with alterations in endothelial
function (e.g., reduction in migration and proliferation), and
a small increase in apoptotic markers has been reported with
endothelial erythrophagocytosis in vitro (Fens et al., 2012;
Catan et al., 2019). Additionally, engulfment of microspheres
by the brain endothelium and subsequent migration into the
brain parenchyma is associated with temporary blood–brain
barrier opening in a microembolization rat model (van der
Wijk et al., 2020). Therefore, the increased RBC or iron
load within the brain endothelial cells might trigger temporal
endothelial remodeling or dysfunction resulting in blood–
brain barrier changes. These changes may further increase
the extravasation of RBCs and/or RBC degradation products
into the brain, increasing the likelihood of iron-rich lesion
development. Future work using intravital imaging will allow
us to examine the causal and temporal relationship between
brain endothelial erythrophagocytosis and blood–brain barrier
permeability at the site of RBC extravasation using tracers
followed by Prussian-blue staining to detect iron-rich lesions.
These studies will also help elucidate how widespread brain
endothelial erythrophagocytosis is, and if brain endothelial
erythrophagocytosis-mediated abluminal iron increase is a focal
or a diffuse event. Notably, our in vivo study showed focal iron
deposits associated with tBHP-RBCs.
Overall, based on the results of the current study we
propose the following sequence of events whereby brain
endothelial erythrophagocytosis may result in iron-rich CMHlike lesion development (Figure 8): oxidative stress and

endothelial cell viability and brain endothelial integrity are not
compromised despite robust erythrophagocytosis and cellular
iron increase (Figure 3 and Supplementary Figure 3).
Our previous work provided in vivo evidence for migration
of tBHP-RBCs across an intact brain endothelium in Tie2GFP mice, while the PBS-RBCs remained confined to the
vasculature (Chang R. et al., 2018). These findings were
recently corroborated by a study showing brain endothelial
erythrophagocytosis of Plasmodium falciparum-infected RBCs
in vivo (Adams et al., 2021). In the current study, we
show that mice injected with tBHP-RBCs had a greater
Prussian blue-positive CMH-like lesion load compared with mice
injected with PBS-RBCs (Figure 7), supporting the in vitro
findings of increased abluminal iron with brain endothelial
erythrophagocytosis (Figure 6). Our previous work using ex vivo
microscopy demonstrated an intact endothelium at the site of
RBC extravasation (Chang R. et al., 2018) as opposed to a
ruptured endothelium, which is seen with Prussian blue-positive
lesions associated with blood–brain barrier damage (Sumbria
et al., 2016). Further, we found no change in the blood–brain
barrier tight junction protein ZO-1 seven days after tBHP-RBC
injection (Figure 7). This is in line with our recent work showing
no association between blood–brain barrier changes with CMH
development in humans (Wadi et al., 2020). Accordingly, our
in vitro data and other reports (Catan et al., 2019) show no
change in brain endothelial cell viability and permeability with
erythrophagocytosis (Figure 3 and Supplementary Figure 3).
However, it is important to note that erythrophagocytosis of

FIGURE 8 | Suggested mechanisms contributing to brain endothelial erythrophagocytosis mediated Prussian blue-positive cerebral lesions. Oxidative stress and
phosphatidylserine exposure increase phagocytosis of RBCs by the brain endothelium. Other mechanisms including CD47 reduction may also be involved. Engulfed
RBCs undergo endosomal sorting and ultimately undergo degradation within the late endosomes/lysosomes. This increases intracellular pools of iron-rich RBC
degradation products, hemoglobin and iron. Free iron may be effluxed from the brain endothelial cells via the abluminal iron-exporter ferroportin. Alternatively,
hemoglobin may migrate across the brain endothelium. Migration of iron-rich RBC degradation products across the brain endothelial cells can increase the brain
abluminal iron, resulting in Prussian blue-positive CMH-like lesion development.

Frontiers in Cell and Developmental Biology | www.frontiersin.org

12

August 2021 | Volume 9 | Article 672009

Sun et al.

Mechanisms of Brain Endothelial Erythrophagocytosis

and RKS performed the experiments and data analysis. APH assisted with the data analysis. ACFN and WLL assisted
with the in vivo study. JS and RKS wrote the first draft of
the manuscript. RKS, DHC, and MJF acquired the funding.
All authors discussed the results and their implications, and
commented on the manuscript. All authors read and approved
the final manuscript.

phosphatidylserine exposure increase phagocytosis of RBCs by
the brain endothelium. Other mechanisms including CD47
reduction may also contribute to this process. A subset of
engulfed RBCs undergoes endosomal sorting and degradation.
RBC engulfment and degradation increase intracellular pools
of iron-rich RBC degradation products, hemoglobin and iron.
Free iron may be effluxed from the brain endothelial cells via
the iron exporter ferroportin. Additionally, hemoglobin may
migrate across the brain endothelium (Chang R. et al., 2018).
Both iron and hemoglobin migration across the brain endothelial
cells increases brain abluminal iron, which results in Prussian
blue-positive CMH-like lesion development.
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